Edition:
United States

Insider Trading: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,474.00GBp
22 Sep 2017
Change (% chg)

6.00 (+0.41%)
Prev Close
1,468.00
Open
1,462.50
Day's High
1,483.00
Day's Low
1,460.50
Volume
6,466,859
Avg. Vol
8,808,788
52-wk High
1,745.56
52-wk Low
1,444.00

All Insider Trades

Institutional Holders

% Shares Owned: 51.00%
# of Holders: 732
Total Shares Held: 2,508,509,041
3 Mo. Net Change: -67,883,966
# New Positions: 22
# Closed Positions: 28
# Increased Positions: 199
# Reduced Positions: 207
# Net Buyers: -8

Officers & Directors

Name Age Since Current Position

Philip Hampton

63 2015 Non-Executive Chairman of the Board

Emma Walmsley

46 2017 Chief Executive Officer - Designate, Executive Director

Simon Dingemans

52 2011 Chief Financial Officer, Executive Director

Patrick Vallance

2017 President - Pharmaceuticals R&D, Executive Director

Roger Connor

2013 President - Global Manufacturing & Supply

Abbas Hussain

2014 President - Global Pharmaceuticals

Shah Abbas Hussain

2015 President - Global Pharmaceuticals

Luke Miels

2017 President - Global Pharmaceuticals

Daniel Troy

2008 Senior Vice President, General Counsel

Claire Thomas

2008 Senior Vice President - Human Resources

Nick Hirons

2014 Senior Vice President – Global Ethics and Compliance

Phil Thomson

2014 Senior Vice President - Communications and Government Affairs

David Redfern

50 2008 Chief Strategy Officer

Victoria Whyte

2011 Company Secretary

Laurie Glimcher

2017 Non-Executive Director

Roy Anderson

68 2007 Non-Executive Independent Director

Manvinder Banga

62 2015 Non-Executive Independent Director

Vindi Banga

2017 Senior Independent Non-Executive Director

Vivienne Cox

58 2017 Non-Executive Independent Director

Lynn Elsenhans

60 2012 Non-Executive Independent Director

Jesse Goodman

64 2017 Non-Executive Independent Director

Judy Lewent

68 2011 Non-Executive Independent Director

Urs Rohner

58 2015 Non-Executive Independent Director